| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Revenue | $8.03B | +16.5% |
| Cost of Revenue | $2.06B | +7.8% |
| Gross Profit | $5.97B | +19.8% |
| R&D Expense | $1.81B | +12.8% |
| SG&A Expense | $680.5M | +52.0% |
| Operating Income | $683.9M | +76.6% |
| Interest Expense | $8.3M | -69.5% |
| Pre-tax Income | $988.3M | +74.5% |
| Income Tax | -$1.59B |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.54B | +35.2% |
| Short-term Investments | $1.04B | -16.8% |
| Accounts Receivable | $2.62B | +6.3% |
| Current Assets | $6.85B | +13.3% |
| Total Assets | $19.99B | +37.9% |
| Current Liabilities | $7.68B | -0.7% |
| Total Liabilities | $14.82B | +16.2% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.26B | +17.3% |
| Investing Cash Flow | -$1.51B | +25.8% |
| Financing Cash Flow | -$1.34B | +22.2% |
| -1355.4% |
| Net Income | $2.58B | +486.2% |
| EPS (Basic) | $8.07 | +456.6% |
| EPS (Diluted) | $7.28 | +468.8% |
| Stockholders' Equity |
| $5.17B |
| +195.7% |